458 related articles for article (PubMed ID: 36748905)
1. Long COVID in cancer patients: preponderance of symptoms in majority of patients over long time period.
Dagher H; Chaftari AM; Subbiah IM; Malek AE; Jiang Y; Lamie P; Granwehr B; John T; Yepez E; Borjan J; Reyes-Gibby C; Flores M; Khawaja F; Pande M; Ali N; Rojo R; Karp DD; Chaftari P; Hachem R; Raad II
Elife; 2023 Feb; 12():. PubMed ID: 36748905
[TBL] [Abstract][Full Text] [Related]
2. Long COVID outcomes following omicron wave in non-hospital population.
Ruiyin W; Qi J; Tingting W; Yuqin Y; Yan J; Kun P
Front Public Health; 2024; 12():1377866. PubMed ID: 38560433
[TBL] [Abstract][Full Text] [Related]
3. A longitudinal SARS-CoV-2 biorepository for COVID-19 survivors with and without post-acute sequelae.
LaVergne SM; Stromberg S; Baxter BA; Webb TL; Dutt TS; Berry K; Tipton M; Haberman J; Massey BR; McFann K; Alnachoukati O; Zier L; Heacock T; Ebel GD; Henao-Tamayo M; Dunn J; Ryan EP
BMC Infect Dis; 2021 Jul; 21(1):677. PubMed ID: 34256735
[TBL] [Abstract][Full Text] [Related]
4. Subphenotypes of self-reported symptoms and outcomes in long COVID: a prospective cohort study with latent class analysis.
Kitsios GD; Blacka S; Jacobs JJ; Mirza T; Naqvi A; Gentry H; Murray C; Wang X; Golubykh K; Qurashi H; Dodia A; Risbano M; Benigno M; Emir B; Weinstein E; Bramson C; Jiang L; Dai F; Szigethy E; Mellors JW; Methe B; Sciurba FC; Nouraie SM; Morris A
BMJ Open; 2024 Mar; 14(3):e077869. PubMed ID: 38485476
[TBL] [Abstract][Full Text] [Related]
5. Development of a Definition of Postacute Sequelae of SARS-CoV-2 Infection.
Thaweethai T; Jolley SE; Karlson EW; Levitan EB; Levy B; McComsey GA; McCorkell L; Nadkarni GN; Parthasarathy S; Singh U; Walker TA; Selvaggi CA; Shinnick DJ; Schulte CCM; Atchley-Challenner R; Alba GA; Alicic R; Altman N; Anglin K; Argueta U; Ashktorab H; Baslet G; Bassett IV; Bateman L; Bedi B; Bhattacharyya S; Bind MA; Blomkalns AL; Bonilla H; Brim H; Bush PA; Castro M; Chan J; Charney AW; Chen P; Chibnik LB; Chu HY; Clifton RG; Costantine MM; Cribbs SK; Davila Nieves SI; Deeks SG; Duven A; Emery IF; Erdmann N; Erlandson KM; Ernst KC; Farah-Abraham R; Farner CE; Feuerriegel EM; Fleurimont J; Fonseca V; Franko N; Gainer V; Gander JC; Gardner EM; Geng LN; Gibson KS; Go M; Goldman JD; Grebe H; Greenway FL; Habli M; Hafner J; Han JE; Hanson KA; Heath J; Hernandez C; Hess R; Hodder SL; Hoffman MK; Hoover SE; Huang B; Hughes BL; Jagannathan P; John J; Jordan MR; Katz SD; Kaufman ES; Kelly JD; Kelly SW; Kemp MM; Kirwan JP; Klein JD; Knox KS; Krishnan JA; Kumar A; Laiyemo AO; Lambert AA; Lanca M; Lee-Iannotti JK; Logarbo BP; Longo MT; Luciano CA; Lutrick K; Maley JH; Mallett G; Marathe JG; Marconi V; Marshall GD; Martin CF; Matusov Y; Mehari A; Mendez-Figueroa H; Mermelstein R; Metz TD; Morse R; Mosier J; Mouchati C; Mullington J; Murphy SN; Neuman RB; Nikolich JZ; Ofotokun I; Ojemakinde E; Palatnik A; Palomares K; Parimon T; Parry S; Patterson JE; Patterson TF; Patzer RE; Peluso MJ; Pemu P; Pettker CM; Plunkett BA; Pogreba-Brown K; Poppas A; Quigley JG; Reddy U; Reece R; Reeder H; Reeves WB; Reiman EM; Rischard F; Rosand J; Rouse DJ; Ruff A; Saade G; Sandoval GJ; Santana JL; Schlater SM; Sciurba FC; Shepherd F; Sherif ZA; Simhan H; Singer NG; Skupski DW; Sowles A; Sparks JA; Sukhera FI; Taylor BS; Teunis L; Thomas RJ; Thorp JM; Thuluvath P; Ticotsky A; Tita AT; Tuttle KR; Urdaneta AE; Valdivieso D; VanWagoner TM; Vasey A; Verduzco-Gutierrez M; Wallace ZS; Ward HD; Warren DE; Weiner SJ; Welch S; Whiteheart SW; Wiley Z; Wisnivesky JP; Yee LM; Zisis S; Horwitz LI; Foulkes AS;
JAMA; 2023 Jun; 329(22):1934-1946. PubMed ID: 37278994
[TBL] [Abstract][Full Text] [Related]
6. Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.
Haran JP; Pinero JC; Zheng Y; Palma NA; Wingertzahn M
Trials; 2021 Apr; 22(1):245. PubMed ID: 33810796
[TBL] [Abstract][Full Text] [Related]
7. Effects of pulmonary rehabilitation on functional and psychological parameters in post-acute sequelae of SARS-CoV-2 infection (PASC) patients.
Nasrullah A; Virk S; Javed A; Shah A; Ramanujam D; Sharma A; Gutierrez L; Nauer K; Maggio M; Yin Y; Bajwa Y; Cheema T; Disilvio B
BMC Pulm Med; 2024 May; 24(1):231. PubMed ID: 38745298
[TBL] [Abstract][Full Text] [Related]
8. Long COVID in pediatrics-epidemiology, diagnosis, and management.
Toepfner N; Brinkmann F; Augustin S; Stojanov S; Behrends U
Eur J Pediatr; 2024 Apr; 183(4):1543-1553. PubMed ID: 38279014
[TBL] [Abstract][Full Text] [Related]
9. Real-world effectiveness of COVID-19 vaccines and anti-SARS-CoV-2 monoclonal antibodies against postacute sequelae of SARS-CoV-2: analysis of a COVID-19 observational registry for a diverse US metropolitan population.
Tannous J; Pan AP; Potter T; Bako AT; Dlouhy K; Drews A; Sostman HD; Vahidy FS
BMJ Open; 2023 Apr; 13(4):e067611. PubMed ID: 37019490
[TBL] [Abstract][Full Text] [Related]
10. Post COVID-19 sequelae: A prospective observational study from Northern India.
Naik S; Haldar SN; Soneja M; Mundadan NG; Garg P; Mittal A; Desai D; Trilangi PK; Chakraborty S; Begam NN; Bhattacharya B; Maher G; Mahishi N; Rajanna C; Kumar SS; Arunan B; Kirtana J; Gupta A; Patidar D; Kodan P; Sethi P; Ray A; Jorwal P; Kumar A; Nischal N; Sinha S; Biswas A; Wig N
Drug Discov Ther; 2021 Nov; 15(5):254-260. PubMed ID: 34719599
[TBL] [Abstract][Full Text] [Related]
11. Prevalence and determinants of post-acute sequelae of COVID-19 in Liberia.
Gwaikolo C; Sackie-Wapoe Y; Badio M; Glidden DV; Lindan C; Martin J
Int J Epidemiol; 2024 Feb; 53(1):. PubMed ID: 38052015
[TBL] [Abstract][Full Text] [Related]
12. [Complaints and clinical findings six months after COVID-19: outpatient follow-up at the University Medical Center Freiburg].
August D; Stete K; Hilger H; Götz V; Biever P; Hosp J; Wagner D; Köhler TC; Gerstacker K; Seufert J; Laubner K; Kern W; Rieg S
Dtsch Med Wochenschr; 2021 Sep; 146(17):e65-e73. PubMed ID: 34425627
[TBL] [Abstract][Full Text] [Related]
13. Mid and long-term neurological and neuropsychiatric manifestations of post-COVID-19 syndrome: A meta-analysis.
Premraj L; Kannapadi NV; Briggs J; Seal SM; Battaglini D; Fanning J; Suen J; Robba C; Fraser J; Cho SM
J Neurol Sci; 2022 Mar; 434():120162. PubMed ID: 35121209
[TBL] [Abstract][Full Text] [Related]
14. Risk factors associated with post-acute sequelae of SARS-CoV-2: an N3C and NIH RECOVER study.
Hill EL; Mehta HB; Sharma S; Mane K; Singh SK; Xie C; Cathey E; Loomba J; Russell S; Spratt H; DeWitt PE; Ammar N; Madlock-Brown C; Brown D; McMurry JA; Chute CG; Haendel MA; Moffitt R; Pfaff ER; Bennett TD; ;
BMC Public Health; 2023 Oct; 23(1):2103. PubMed ID: 37880596
[TBL] [Abstract][Full Text] [Related]
15. Neurological post-acute sequelae of SARS-CoV-2 infection.
Takao M; Ohira M
Psychiatry Clin Neurosci; 2023 Feb; 77(2):72-83. PubMed ID: 36148558
[TBL] [Abstract][Full Text] [Related]
16. Prevalence and determinants of post-acute sequelae after SARS-CoV-2 infection (Long COVID) among adults in Mexico during 2022: a retrospective analysis of nationally representative data.
Bello-Chavolla OY; Fermín-Martínez CA; Ramírez-García D; Vargas-Vázquez A; Fernández-Chirino L; Basile-Alvarez MR; Sánchez-Castro P; Núñez-Luna A; Antonio-Villa NE
Lancet Reg Health Am; 2024 Feb; 30():100688. PubMed ID: 38327277
[TBL] [Abstract][Full Text] [Related]
17. Prevalence and impact of COVID-19 sequelae on treatment and survival of patients with cancer who recovered from SARS-CoV-2 infection: evidence from the OnCovid retrospective, multicentre registry study.
Pinato DJ; Tabernero J; Bower M; Scotti L; Patel M; Colomba E; Dolly S; Loizidou A; Chester J; Mukherjee U; Zambelli A; Dalla Pria A; Aguilar-Company J; Ottaviani D; Chowdhury A; Merry E; Salazar R; Bertuzzi A; Brunet J; Lambertini M; Tagliamento M; Pous A; Sita-Lumsden A; Srikandarajah K; Colomba J; Pommeret F; Seguí E; Generali D; Grisanti S; Pedrazzoli P; Rizzo G; Libertini M; Moss C; Evans JS; Russell B; Harbeck N; Vincenzi B; Biello F; Bertulli R; Liñan R; Rossi S; Carmona-García MC; Tondini C; Fox L; Baggi A; Fotia V; Parisi A; Porzio G; Saponara M; Cruz CA; García-Illescas D; Felip E; Roqué Lloveras A; Sharkey R; Roldán E; Reyes R; Earnshaw I; Ferrante D; Marco-Hernández J; Ruiz-Camps I; Gaidano G; Patriarca A; Bruna R; Sureda A; Martinez-Vila C; Sanchez de Torre A; Cantini L; Filetti M; Rimassa L; Chiudinelli L; Franchi M; Krengli M; Santoro A; Prat A; Van Hemelrijck M; Diamantis N; Newsom-Davis T; Gennari A; Cortellini A;
Lancet Oncol; 2021 Dec; 22(12):1669-1680. PubMed ID: 34741822
[TBL] [Abstract][Full Text] [Related]
18. Postdischarge rheumatic and musculoskeletal symptoms following hospitalization for COVID-19: prospective follow-up by phone interviews.
Karaarslan F; Demircioğlu Güneri F; Kardeş S
Rheumatol Int; 2021 Jul; 41(7):1263-1271. PubMed ID: 33978818
[TBL] [Abstract][Full Text] [Related]
19. Clinical Features and Burden of Postacute Sequelae of SARS-CoV-2 Infection in Children and Adolescents.
Rao S; Lee GM; Razzaghi H; Lorman V; Mejias A; Pajor NM; Thacker D; Webb R; Dickinson K; Bailey LC; Jhaveri R; Christakis DA; Bennett TD; Chen Y; Forrest CB
JAMA Pediatr; 2022 Oct; 176(10):1000-1009. PubMed ID: 35994282
[TBL] [Abstract][Full Text] [Related]
20. Plasma proteomics show altered inflammatory and mitochondrial proteins in patients with neurologic symptoms of post-acute sequelae of SARS-CoV-2 infection.
Hanson BA; Visvabharathy L; Orban ZS; Jimenez M; Batra A; Liotta EM; DeLisle RK; Klausner JD; Cohen P; Padhye AS; Tachas G; Koralnik IJ
Brain Behav Immun; 2023 Nov; 114():462-474. PubMed ID: 37704012
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
